Theravance Biopharma, Inc. Shares Outstanding (Cover Page)
Theravance Biopharma, Inc. (TBPH) had Shares Outstanding (Cover Page) of 51.92 million shares as of 2026-07-31, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-07-31: Entity Common Stock, Shares Outstanding 51.92M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 51.55M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 51.49M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 50.67M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 51.92M shares 10-Q · filed 2026-08-11 |
| 2026-04-30 | 51.55M shares 10-Q · filed 2026-05-07 |
| 2026-02-28 | 51.49M shares 10-K · filed 2026-03-23 |
| 2025-11-03 | 50.67M shares 10-Q · filed 2025-11-12 |
| 2025-08-01 | 50.36M shares 10-Q · filed 2025-08-13 |
| 2025-05-02 | 50.00M shares 10-Q · filed 2025-05-12 |
| 2025-02-21 | 49.47M shares 10-K · filed 2025-03-07 |
| 2024-11-08 | 49.17M shares 10-Q · filed 2024-11-14 |
| 2024-08-02 | 48.92M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 48.63M shares 10-Q · filed 2024-05-15 |
| 2024-02-23 | 48.16M shares 10-K · filed 2024-03-01 |
| 2023-11-01 | 49.80M shares 10-Q · filed 2023-11-09 |
| 2023-08-01 | 52.81M shares 10-Q · filed 2023-08-09 |
| 2023-05-01 | 57.80M shares 10-Q/A · filed 2023-05-18 |
| 2023-02-21 | 62.86M shares 10-K · filed 2023-03-01 |
| 2022-10-31 | 67.37M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 76.43M shares 10-Q · filed 2022-08-08 |
| 2022-04-29 | 76.12M shares 10-Q · filed 2022-05-06 |
| 2022-02-21 | 74.70M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 73.70M shares 10-Q · filed 2021-11-08 |
| 2021-07-30 | 73.47M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 65.28M shares 10-Q · filed 2021-05-06 |
| 2021-02-19 | 64.33M shares 10-K · filed 2021-02-26 |
| 2020-10-30 | 63.98M shares 10-Q · filed 2020-11-09 |
| 2020-07-31 | 63.52M shares 10-Q · filed 2020-08-10 |
| 2020-04-30 | 63.09M shares 10-Q · filed 2020-05-08 |
| 2020-02-19 | 62.52M shares 10-K · filed 2020-02-27 |
| 2019-10-25 | 56.76M shares 10-Q · filed 2019-11-08 |
| 2019-07-26 | 56.64M shares 10-Q · filed 2019-08-05 |
| 2019-04-30 | 56.14M shares 10-Q · filed 2019-05-10 |
| 2019-02-15 | 55.58M shares 10-K · filed 2019-02-28 |
| 2018-10-31 | 55.41M shares 10-Q · filed 2018-11-08 |
| 2018-07-31 | 55.10M shares 10-Q · filed 2018-08-02 |
| 2018-05-01 | 54.85M shares 10-Q · filed 2018-05-09 |
| 2018-01-31 | 54.38M shares 10-K · filed 2018-02-28 |
| 2017-11-01 | 54.10M shares 10-Q · filed 2017-11-08 |
| 2017-08-01 | 53.83M shares 10-Q · filed 2017-08-09 |
| 2017-05-01 | 53.36M shares 10-Q · filed 2017-05-10 |
| 2017-01-31 | 52.86M shares 10-K · filed 2017-03-01 |
| 2016-11-03 | 51.94M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 47.85M shares 10-Q · filed 2016-08-09 |
| 2016-05-05 | 47.48M shares 10-Q · filed 2016-05-10 |
| 2016-02-29 | 38.43M shares 10-K · filed 2016-03-11 |
| 2015-10-31 | 37.84M shares 10-Q · filed 2015-11-12 |
| 2015-07-31 | 33.94M shares 10-Q · filed 2015-08-13 |
| 2015-04-30 | 33.80M shares 10-Q · filed 2015-05-13 |
| 2015-02-28 | 33.80M shares 10-K · filed 2015-03-13 |
| 2014-10-31 | 32.23M shares 10-Q · filed 2014-11-12 |
| 2014-07-31 | 32.23M shares 10-Q · filed 2014-08-14 |
| 2014-06-06 | 32.26M shares 10-Q · filed 2014-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |